Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

NCT00233714 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CYPHER Sirolimus-Eluting Coronary Stent
DEVICE: CYPHER Sirolimus-Eluting Coronary Stent

Sponsor

Cordis US Corp.